The Concerning Rise of Syphilis & the Critical Bicillin-L-A Shortage: A Public Health Viewpoint
Syphilis, a sexually transmitted infection (STI) once considered a disease of the past, is unfortunately making a important and alarming comeback. As a healthcare professional with years of experience in infectious disease management, I’m deeply concerned by the recent surge in cases, especially the heartbreaking rise in congenital syphilis – infection passed from mother to baby. This isn’t just a medical issue; it’s a public health crisis demanding immediate attention and a multi-faceted approach.Understanding Syphilis: From Initial Infection to Serious Complications
Syphilis is caused by the bacterium Treponema pallidum and is typically spread through direct contact with a syphilis sore, known as a chancre. These sores often appear on the genitals, anus, or mouth. The infection progresses in stages. Early syphilis is often easily treated with antibiotics, typically penicillin. However, if left untreated, the consequences can be devastating.
Later stages of syphilis can inflict serious damage on vital organs, including the brain, heart, and nervous system. Symptoms can be subtle and develop over years, making early detection crucial. This is why routine screening is so critically important.The Heartbreaking Reality of Congenital Syphilis
The most devastating aspect of the current resurgence is the dramatic increase in congenital syphilis. In 2023, we saw a staggering 3,800 cases reported, a tenfold increase from the 335 cases reported in 2012. this isn’t just a statistic; it represents preventable suffering. Congenital syphilis can lead to miscarriage, stillbirth, and tragically, infant death.Babies born with syphilis can face a lifetime of medical challenges, including developmental delays, neurological problems, and even blindness.
Prevention is Paramount: The Role of Prenatal Care
The good news is that congenital syphilis is preventable.The key lies in thorough prenatal care that includes routine syphilis screening for all pregnant women.Many states already mandate testing, and others are actively implementing ”opt-out” screening programs. This proactive approach means that all pregnant women presenting for care – even in emergency rooms – are automatically tested unless they specifically decline.However, screening is only half the battle. we must also ensure access to timely and effective treatment for those who test positive.
The Bicillin-L-A Shortage: A Major Obstacle to Treatment
This brings us to the current crisis: a critical shortage of Bicillin-L-A, the preferred treatment for syphilis, especially in pregnant women. Bicillin-L-A is a long-acting injectable penicillin, offering several advantages. It’s often easier for patients to adhere to a single injection compared to a course of oral medication, and it minimizes the risk of missed doses – a critical factor in ensuring prosperous treatment.
Unfortunately,we’ve been grappling with Bicillin-L-A shortages for years. The first significant shortage lasted nearly five years, beginning in 2005. Another shortage emerged in 2017, attributed to increased demand by manufacturer Pfizer. Then, in June 2023, pfizer announced a manufacturing delay, extending the shortage through 2024.The current shortage stems from a voluntary recall initiated on July 10th, 2023, due to the presence of particles in some vials. While no harm has been reported, Pfizer proactively recalled affected lots (you can find details on affected lots here:[https://wwwpfizerhospitaluscom/sites/default/files/news[https://wwwpfizerhospitaluscom/sites/default/files/news[https://wwwpfizerhospitaluscom/sites/default/files/news[https://wwwpfizerhospitaluscom/sites/default/files/newsannouncements/Bicillin%20Recall%20Letter.pdf?acstrackingid=USCDCNPIN162-DM148644&ACSTrackingLabel=Voluntary%20recall%20of%20Bicillin%C2%AE%20L-A%20(Penicillin%20G%20Benzathine%20Injectable%20Suspension)&deliveryName=USCDCNPIN162-DM148644](https://www.pfizerhospitalus.com/sites/default/files/newsannouncements/Bicillin%20Recall%20Letter.pdf?ACSTrackingID=USCDCNPIN_162-DM148644&ACSTrackingLabel=Voluntary%20recall%